neurosurgery

Devices & Diagnostics

Healthcare business intelligence: Covidien to sell Confluent Surgical line to Integra LifeSciences

Covidien (COV) announced it will sell its Confluent Surgical line to Integra LifeSciences (IART) probably effective by March 31, 2014, pending regulatory approval. The product line brought in $65 million for the medical devices company in 2012. Integra will pay $235 million for the line, which includes DuraSeal, the first FDA-approved product that provides watertight […]

presented by